Person

Michael S. Aberman

Formerly SVP Strategy Investor Relation, Regeneron Pharmaceuticals

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$1.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jun 22, 2017REGNSale395$525.21$207K
Jun 22, 2017REGNSale100$526.02$53K
Jun 22, 2017REGNSale100$529.61$53K
Jun 22, 2017REGNSale100$530.66$53K
Jun 22, 2017REGNSale274$531.51$146K
Jun 22, 2017REGNSale200$532.27$106K
Jun 22, 2017REGNSale200$533.48$107K
Jun 22, 2017REGNSale200$534.51$107K
Jun 22, 2017REGNSale400$536.52$215K
Jun 22, 2017REGNSale100$537.50$54K
Jun 22, 2017REGNSale100$538.30$54K
Jun 22, 2017REGNSale100$541.00$54K

SEC reporting-owner ID (CIK) 1487767 · all filings on EDGAR